Recruiting

Imaging CorrelationDiffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation

Sponsor:

The University of Texas Health Science Center, Houston

Code:

NCT02846272

Conditions

Intractable Epilepsy

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Observation

Study Details

Brief summary:

To determine the utility of diffusion tensor magnetic resonance imaging in the preoperative workup of children with intractable epilepsy referred for surgery.

Conditions

Intractable Epilepsy

Study ID

NCT02846272

Start date

Nov, 2015

Status verified date

Dec, 2024

Completion date

Jan 1, 2031

Anticipated

Primary completion date

Jan 1, 2030

Anticipated

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

Children diagnosis with Intractable Epilepsy

Exclusion Criteria:

No Intractable Epilepsy

Study Design

Enrollment

50 participants

Anticipated

Intervention Model

Single group

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

experimental: Observational cohort

Observing MRI changes in subjects.

Interventions

Observation

Observation of MRI changes in subjects

Primary outcome measure

Number of participants with seizure outcome as determined by Engel [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Manish N Shah, M.D.

713 500-7410 Manish.N.Shah@uth.tmc.edu

Bangning L Yu, R.N., PhD

713 500-7363 Bangning.Yu@uth.tmc.edu

Locations

UTHealth & Children's Memorial Hermann Hospital

Recruiting

Houston, Texas, United States, 77030

Contacts

Manish N Shah, M.D.

713-500-7410 Manish.N.Shah@uth.tmc.edu

Bangning L Yu, R.N., PhD

713 500-7363 Bangning.Yu@uth.tmc.edu

More Information

Sponsor

The University of Texas Health Science Center, Houston

Last update posted

Dec 11, 2024

Last verified

Dec, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by The University of Texas Health Science Center, Houston on 2024-12-11.